ETHZilla Corp, a publicly traded Ethereum treasury firm, has executed a 1-for-10 reverse stock split for its common stock, ETHZ, with the action set to take effect on October 20, 2025. The move, approved by the company's Board of Directors and detailed in an SEC Form 8-K filing, aims to increase the share price to attract institutional investors by aligning with standards like mutual fund minimum share price limitations.
The reverse stock split will reduce outstanding shares from approximately 160 million to 16 million, as part of ETHZilla's strategy to enhance collateral and margin availability for investors. However, shares fell nearly 5% following the announcement, closing at $1.83 on the day, though the stock has risen over 105% in the past six months.
ETHZilla holds about 102,246 ETH valued at around $407 million, positioning it as the sixth-largest publicly traded Ethereum treasury. The firm, which rebranded from 180 Life Sciences in late July, emphasized that the stock split has no direct impact on Ethereum or broader cryptocurrency prices, according to SEC disclosures and company statements.
In a post on X, ETHZilla stated the decision reflects a strategic alignment with institutional standards to enable broader participation and long-term growth. John Kristoff, SVP of Corporate Communications and IR, added that ETH accumulation remains unaffected, with the company focusing on tokenization solutions, DeFi protocol integration, and other services bridging traditional and decentralized finance.
